T 1869/11 (Treatment of respiratory disorders/OCKHAM BIOTECH LIMITED) of 22.03.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T186911.20130322
- Date of decision
- 22 March 2013
- Case number
- T 1869/11
- Petition for review of
- -
- Application number
- 03704789.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of glycosaminoglycans such as E.G. heparin for the treatment of respiratory disorders such as COPD
- Applicant name
- Ockham Biotech Limited
- Opponent name
- Vectura Limited
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- New main request - admission (yes)
Added matter (no)
Sufficiency of disclosure, novelty and inventive step (yes)
Remittal (no) - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the main request filed during the oral proceedings, and a description to be adapted thereto.